Content area

Abstract

Genetic mapping and genome-wide studies provide evidence for the association of several genetic polymorphisms with malaria, a complex pathological disease with multiple severity degrees. We have previously described Berr1and Berr2 as candidate genes identified in the WLA/Pas inbreed mouse strain predisposing to resistance to cerebral malaria (CM) induced by P. berghei ANKA. We report in this study the phenotypic and functional characteristics of a congenic strain we have derived for Berr2WLA allele on the C57BL/6JR (B6) background. B6.WLA-Berr2 was found highly resistant to CM compared to C57BL/6JR susceptible mice. The mechanisms associated with CM resistance were analyzed by combining genotype, transcriptomic and immune response studies. We found that B6.WLA-Berr2 mice showed a reduced parasite sequestration and blood–brain barrier disruption with low CXCR3+ T cell infiltration in the brain along with altered glial cell response upon P. berghei ANKA infection compared to B6. In addition, we have identified the CD300f, belonging to a family of Ig-like encoding genes, as a potential candidate associated with CM resistance. Microglia cells isolated from the brain of infected B6.WLA-Berr2 mice significantly expressed higher level of CD300f compared to CMS mice and were associated with inhibition of inflammatory response.

Details

Title
Expression of CD300lf by microglia contributes to resistance to cerebral malaria by impeding the neuroinflammation
Author
Keswani Tarun 1 ; Jacques, Roland 1 ; Herbert, Fabien 1 ; Delcroix-Genete Delphine 1 ; Bauderlique-Le, Roy Hélène 2 ; Gaayeb Lobna 1 ; Pierre-André, Cazenave 3 ; Pied Sylviane 1   VIAFID ORCID Logo 

 Université de Lille, Center for Infection and Immunity of Lille, CNRS UMR 8204, Inserm 1019, Institut Pasteur de Lille, Lille, France (GRID:grid.463727.3) (ISNI:0000 0004 0386 3856) 
 CIIL, Institut Pasteur de Lille, Flow Cytometry Core Facility, BioImaging Center Lille, Lille, France (GRID:grid.463727.3) (ISNI:0000 0004 0386 3856) 
 Université de Lille, Center for Infection and Immunity of Lille, CNRS UMR 8204, Inserm 1019, Institut Pasteur de Lille, Lille, France (GRID:grid.463727.3) (ISNI:0000 0004 0386 3856); UPMC/CNRS UMR 7211, Immunologie—Immunopathologie—Immunothérapie, Paris, France (GRID:grid.463727.3) 
Pages
45-62
Publication year
2020
Publication date
Jan 2020
Publisher
Nature Publishing Group
ISSN
14664879
e-ISSN
14765470
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2363001507
Copyright
2019© The Author(s), under exclusive licence to Springer Nature Limited 2019